By Matt Harrington, BCBA · Behaviorist Book Club · April 2026 · 12 min read

In-Person vs. Remote Supervision: Evidence-Based Practice for ABA Telehealth

Overview & Clinical Significance

The rapid expansion of telehealth ABA services during and following the COVID-19 pandemic produced a natural experiment in remote supervision delivery — one that the field is still processing empirically. Before the pandemic, telehealth research in ABA was sparse and largely focused on parent training and remote consultation rather than direct supervision of behavior technicians. The sudden shift to remote service delivery created both urgent practice need and, gradually, research opportunity.

Britt Farley's work comparing in-person and remote supervision effects on RBT treatment integrity and child behavior addresses this gap directly. The core clinical question is whether supervision can be effectively delivered remotely while maintaining the treatment integrity outcomes that in-person supervision has traditionally supported. The answer, emerging from the comparative research, is that remote supervision can achieve equivalent treatment integrity outcomes when designed and implemented with appropriate protocols — but that 'telehealth by default' without deliberate protocol adaptation does not reliably achieve those outcomes.

For BCBAs with supervisory responsibilities, the significance extends well beyond pandemic emergency response. Telehealth supervision enables service delivery in geographic areas where qualified BCBAs are unavailable for in-person supervision, reduces travel burden for supervisors serving geographically distributed clients, and allows families to access services when transportation or scheduling constraints prevent in-person attendance. These structural advantages make remote supervision a permanent feature of the ABA service landscape, not a temporary accommodation.

The research base matters here because the clinical stakes are real. RBT treatment integrity — how accurately technicians implement behavior plans — is the proximal driver of client behavioral outcomes. If remote supervision produces lower treatment integrity than in-person supervision, the clients served by remote models are receiving less effective treatment. Farley's comparative analysis allows practitioners to identify what specific supervision elements require adaptation in remote contexts to maintain the effectiveness of in-person delivery.

For BCBAs in supervisory roles, the course's comparative framing also addresses a question that has real resource allocation implications: how much in-person supervision is actually necessary for maintaining treatment integrity, and when can remote supervision be safely substituted? Organizations that answer this question based on administrative convenience — defaulting to remote when it saves travel time — are making clinical decisions on non-clinical grounds. Farley's comparative analysis provides the empirical framework for making these decisions on clinical grounds: based on what the data shows about individual supervisee treatment integrity across modalities, client behavioral outcomes across formats, and the specific supervision components where in-person delivery is most critical.

The significance also extends to equity in access to ABA supervision. In geographic areas with high demand for BCBA supervision and limited supply of local BCBAs, remote supervision enables service delivery that would otherwise be impossible. The families and clients who benefit from this expanded access deserve the same quality of supervision outcomes that in-person models provide. Understanding what it takes to achieve equivalent outcomes in remote delivery — not just assuming equivalence because the BACB allows it — is the clinical foundation for delivering equitable supervision quality regardless of geography.

Background & Context

Pre-pandemic telehealth research in ABA established proof-of-concept for several remote service delivery models: parent training via videoconference, consultative support for school-based practitioners, and remote assessment for families in rural areas. This literature identified both the potential of remote delivery and its limitations — particularly around the quality of behavioral observation possible through camera-mediated sessions and the challenges of providing real-time feedback to RBTs during live client sessions.

The barriers identified in pre-pandemic research were largely confirmed as real constraints when telehealth expanded rapidly in 2020. Technology failures, camera angle limitations, audio delays, and the absence of physical proximity all affect the supervisor's ability to observe subtle behavioral nuances and provide timely feedback. Families and RBTs without reliable high-speed internet faced additional access barriers. And the clinical populations served by ABA — many of whom have difficulty generalizing across novel contexts — sometimes showed significant treatment effects from the shift in environmental conditions alone.

Farley's BCBA-D expertise in Washington, Nevada, and Texas reflects the cross-jurisdictional complexity of telehealth practice. Telehealth service delivery regulations vary significantly by state, and BCBAs supervising remotely must navigate both BACB requirements and state-level regulations that may impose additional restrictions on the percentage of supervision that can be conducted remotely, the documentation requirements for remote sessions, and the conditions under which remote supervision hours can be counted toward BCBA certification.

The research landscape as of 2022 — when Farley's course was originally aired — was already indicating that the naive version of the question (is remote supervision as good as in-person supervision?) was less useful than the more precise questions: under what conditions does remote supervision achieve equivalent outcomes, what elements of in-person supervision do not transfer to remote delivery, and what remote-specific protocols can compensate for those gaps.

The regulatory landscape adds a complexity layer that purely clinical analysis does not capture. Different states have approached telehealth ABA regulation differently: some have established permanent telehealth parity laws that require insurers to cover remote ABA supervision equivalently to in-person; others maintain restrictions on the proportion of supervision hours that can be conducted remotely for certification purposes; others have not yet developed specific telehealth ABA regulations, leaving practitioners to navigate ambiguity. BCBAs operating across multiple states — common for supervisors working with telehealth platforms that serve clients in multiple markets — must maintain awareness of state-specific requirements alongside BACB standards.

The technology evolution has also been rapid enough that research conducted even two or three years ago may not reflect current platform capabilities. Early telehealth research used video platforms with higher latency, lower resolution, and fewer annotation features than current clinical telehealth platforms. Bug-in-ear technology has become more accessible and reliable. Asynchronous video review with timestamped feedback tools has matured as a clinical resource. BCBAs should be cautious about applying research limitations from earlier telehealth generations as definitive constraints on what current remote supervision can achieve.

Clinical Implications

The most direct clinical implication of the comparative research is the identification of specific supervision components where in-person and remote delivery differ in effectiveness. Real-time feedback during live sessions — a high-impact supervision component — is substantially more technically challenging to deliver remotely. The latency issues, camera angle limitations, and potential client distraction associated with remote supervisor presence all complicate the delivery of the in-the-moment prompts and corrections that in-person supervision supports most naturally.

For RBT treatment integrity specifically, research suggests that the feedback immediacy problem is the most significant variable. BCBAs observing remotely can see what is happening and record observations, but providing immediate corrective feedback without disrupting the session is harder via teleconference than in-person. Workarounds that have shown effectiveness in the research include bug-in-ear technology for real-time prompting, structured post-session feedback protocols that deliver specific behavioral feedback immediately after observation ends, and BST-based pre-session preparation that reduces the need for mid-session correction.

For child behavior outcomes — the other dependent variable in Farley's comparative analysis — the research picture is more nuanced. In many cases, children adapt to the remote supervisor presence within a few sessions and do not show persistent behavioral effects from the format change. For some clients, however, remote sessions produce generalization failures: the presence of a screen-based adult in the therapy room may itself function as a discriminative stimulus for different behavior, or the subtle environmental differences of a camera-present session may affect motivating operations in ways that shift behavioral outcomes.

For BCBAs designing remote supervision programs, the clinical implication is systematic assessment rather than assumption: track treatment integrity data across in-person and remote supervision conditions from the beginning, monitor for client-level behavioral effects of the format, and identify which supervisees and which clients show the most significant performance differences between formats. This data guides decisions about when in-person supervision should be maintained versus when remote can be safely substituted.

The implications for documentation practices under remote supervision deserve specific attention. The treatment integrity data that BCBAs collect remotely has different evidentiary characteristics than in-person observation data. Camera angle limitations, audio quality variations, and the observer's reduced access to contextual information all affect the precision of remote observation. BCBAs should document these limitations explicitly when they affect the completeness of an observation, specify what was directly observable versus inferred, and note when technical difficulties reduced observation quality below the standard required for accurate treatment integrity assessment. This documentation honesty is both an ethics requirement and a quality monitoring practice.

For supervisees transitioning from primarily in-person to primarily remote supervision models, the transition itself deserves explicit clinical attention. Supervisees who have developed their clinical skills primarily through in-person supervision with immediate feedback may experience a performance dip when supervision shifts to remote — not because of any real skill loss, but because the feedback immediacy they have relied on is no longer available at the same level. Anticipating this transition effect, implementing bridging strategies (more frequent but shorter remote contacts, explicit self-monitoring protocols), and monitoring treatment integrity data through the transition period reduces the clinical risk of the format shift.

Ethical Considerations

Code 3.01 (Supervisory Responsibilities) applies without modification to remote supervision: the BCBA's obligations to train supervisees, monitor their performance, and provide feedback are not reduced because supervision is delivered remotely. Remote delivery changes the medium; it does not change the standard. BCBAs who accept remote supervision contracts and then provide less comprehensive monitoring or less timely feedback than the standard requires — using remote delivery as a justification for reduced rigor — are not meeting their supervisory obligations.

Code 2.01 (Providing Effective Treatment) creates an obligation to monitor whether remote service delivery is producing equivalent treatment outcomes for each client. The average findings of comparative research cannot substitute for individual client monitoring: even if remote supervision works well on average, a BCBA has an obligation to know whether it is working for the specific clients they serve. Treatment integrity and client behavioral data should be analyzed specifically for remote versus in-person supervision conditions for each client.

Informed consent has specific implications in telehealth contexts. Families should understand that supervision may be occurring remotely, what that means for the supervisor's observation capabilities, and what data will be collected to ensure treatment quality. Code 2.09 (Informed Consent) requires that families consent to service delivery formats, which includes telehealth components.

There are also jurisdiction-specific legal and regulatory considerations that ethics practice requires BCBAs to navigate. State regulations on telehealth ABA services are evolving and vary considerably. Practicing in jurisdictions where remote ABA supervision is not explicitly authorized, or where specific documentation requirements for remote supervision exist, requires awareness and compliance that cannot be assumed from BACB requirements alone.

The documentation obligations under remote supervision are more complex than under in-person supervision and deserve explicit attention in ethics discussions. BCBAs must document not only that supervision occurred but that the remote supervision met the quality standard required — that observation quality was sufficient for treatment integrity assessment, that feedback was delivered with adequate behavioral specificity, and that any technology limitations were noted and addressed. Generic supervision logs that do not distinguish between in-person and remote contacts, or that do not note quality limitations when they occurred, fail to create the accurate record the ethics code's documentation requirements call for.

For BCBAs who provide remote supervision across state lines, the ethics obligations include awareness of and compliance with each jurisdiction's regulations — which requires ongoing monitoring as state telehealth regulations continue to evolve. Operating in a state where remote ABA supervision is not yet authorized, or where specific conditions have not been met, creates legal and ethical exposure that cannot be resolved by BACB compliance alone. BCBAs should treat jurisdiction-specific regulatory compliance as a component of their supervisory responsibilities, not as an administrative concern separate from their clinical and ethical practice.

Assessment & Decision-Making

Assessment for remote supervision program design should begin with three levels of analysis: client-level (which clients are likely to benefit from or be negatively affected by remote supervision components), supervisee-level (which RBTs have demonstrated sufficient skill to maintain treatment integrity under remote supervision, and which require in-person contact for skill development), and technology-level (what platform capabilities and infrastructure are available for remote observation and feedback delivery).

For client-level assessment, the primary variables are: presence and severity of behaviors that require immediate in-person response for safety management, current treatment phase (skill acquisition early in programming typically benefits from more intensive in-person supervision), generalization status (clients who have not yet generalized across contexts may show more significant effects from format changes), and family technology access and comfort.

For supervisee-level assessment, the variables include: current treatment integrity baseline, self-management skills and documentation accuracy in unsupervised conditions, communication skills for seeking help when needed in real time, and technology proficiency. Supervisees who are still acquiring foundational clinical skills typically require more in-person supervision time than those who have reached criterion on core competencies and are maintaining them across sessions.

Decision-making about the proportion of supervision that can occur remotely should be driven by these assessments rather than by administrative convenience. The BACB's minimum supervision requirements specify contact frequency and mode; above that floor, the clinical decision should be driven by what each supervisee-client combination actually requires for treatment integrity maintenance and client outcome achievement.

For organizations building remote supervision infrastructure, the assessment of technology platform capabilities should be treated as a clinical assessment rather than an IT decision. The platform's observation quality, feedback delivery tools, and session documentation features are clinical variables — they determine what kind of supervision is actually possible in the remote format. Platforms that do not support bug-in-ear functionality or equivalent real-time feedback delivery should not be used for supervision of supervisees who require real-time prompting for treatment integrity maintenance. The clinical requirements should drive the technology selection, not the reverse.

Longitudinal monitoring of treatment integrity trends across supervision modalities provides the most clinically informative data for remote supervision program management. Single-session comparisons are insufficient because format effects may take several sessions to stabilize. Tracking treatment integrity over a series of sessions for each modality, and monitoring whether integrity trends diverge over time between modalities, provides a much more reliable basis for decisions about appropriate supervision format proportions for each supervisee-client combination.

What This Means for Your Practice

If you are providing remote supervision, implement systematic treatment integrity monitoring that allows you to detect format effects early. Do not assume that because treatment integrity was adequate before the shift to remote supervision, it will remain adequate after. Track session-by-session integrity data and compare it across supervision modalities for each RBT.

Invest in the feedback immediacy problem. The most significant gap between in-person and remote supervision is real-time feedback delivery, and this gap is addressable with technology: bug-in-ear systems, structured post-observation feedback templates that ensure immediate delivery of specific behavioral feedback, and pre-session preparation via BST that reduces the in-session feedback need.

For supervisees who are still in active skill development phases, maintain higher proportions of in-person supervision than your schedule might seem to require. The efficiency gains of remote delivery are real, but they should not come at the cost of supervisee skill development quality during the phases when the investment in in-person contact produces the most return. Once a supervisee has reached criterion on core clinical skills, the shift toward higher proportions of remote supervision carries lower clinical risk.

For BCBAs developing their remote supervision competencies, the most important practical skill is feedback delivery through electronic channels with the same behavioral specificity that in-person feedback provides. Written feedback via text or annotated video is easily specific — you can reference timestamps, describe exact behavioral sequences, and provide corrective descriptions with precision. Real-time verbal feedback via bug-in-ear or video call requires deliberate practice to achieve that same specificity under live observation conditions. Developing and practicing a feedback language that is specific, behavior-referenced, and immediately actionable — before you need it in high-stakes clinical situations — is the preparation that remote supervision competence requires.

At the organizational level, developing clear written protocols for when in-person supervision must be maintained — specific client conditions, supervisee experience levels, or treatment phases that require physical presence — creates consistent decision-making across the organization and protects against the gradual drift toward remote-default that administrative efficiency pressure tends to produce. These protocols should be reviewed regularly against ongoing treatment integrity data to ensure that the criteria remain clinically grounded rather than becoming procedural fixtures disconnected from actual outcome monitoring.

For BCBAs entering telehealth-heavy supervision roles, professional development in remote supervision specifically — not just general BCBA competency development — is warranted. The skills required for effective remote supervision observation, feedback delivery, and supervisory relationship maintenance via videoconference differ sufficiently from in-person supervision skills that explicit training and supervised practice in remote delivery is clinically justified. Treating remote supervision proficiency as automatically acquired through general supervisory competence understates the specific skill development the format requires.